Wells Fargo’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-49,600
Closed -$49K 6645
2019
Q3
$49K Buy
+49,600
New +$486K ﹤0.01% 5559
2017
Q4
Sell
-104,600
Closed -$90K 6484
2017
Q3
$90K Hold
104,600
﹤0.01% 5270
2017
Q2
$200K Buy
+104,600
New +$2.28M ﹤0.01% 4786
2016
Q4
Sell
-53,200
Closed -$4K 6407
2016
Q3
$4K Sell
53,200
-12,200
-19% -$245K ﹤0.01% 5955
2016
Q2
$12K Hold
65,400
﹤0.01% 5624
2016
Q1
$47K Buy
65,400
+51,700
+377% +$771K ﹤0.01% 5242
2015
Q4
$35K Buy
+13,700
New +$211K ﹤0.01% 5413

Other funds holding PTEN

Wells Fargo's PTEN Position: Q1 2026 in Review

Wells Fargo reduced its Patterson-UTI (PTEN) stake by 45% in Q1 2026, selling an estimated $3.11M and leaving 448,018 shares worth $4.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2618.

Wells Fargo first reported a position in PTEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $209M in Q4 2017. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Wells Fargo held 448,018 shares of Patterson-UTI worth $4.85M as of Q1 2026.
  • Wells Fargo sold 363,607 Patterson-UTI shares in Q1 2026, an estimated $3.11M.
  • Patterson-UTI made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2618 holding.
  • Wells Fargo first reported a position in Patterson-UTI in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Patterson-UTI position peaked at $209M in Q4 2017.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.